Scotia Capital’s Eupraxia Pharmaceuticals EPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.98M | Sell |
1,291,989
-260,690
| -17% | -$1.41M | 0.03% | 235 |
|
|
2025
Q1 | $5.07M | Buy |
1,552,679
+160,960
| +12% | +$526K | 0.03% | 264 |
|
|
2024
Q4 | $4.26M | Sell |
1,391,719
-4,562
| -0.3% | -$14K | 0.02% | 293 |
|
|
2024
Q3 | $3.49M | Buy |
1,396,281
+29,230
| +2% | +$73.1K | 0.02% | 328 |
|
|
2024
Q2 | $3.5M | Buy |
+1,367,051
| New | +$3.5M | 0.02% | 308 |
|